Moreover, we identified widespread hypomethylation status of CpG sites located at genes involved in type I IFN signaling in CD4+ T cells, indicating that GD/RA/SLE/SSc patients might be hypersensitive to type I IFN. This evidence concerns the gene CD4 and systemic lupus erythematosus.